Recruiting A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors. NCT06889610 Conditions Breast Diseases, Breast Neoplasms, Colorectal Cancer Metastatic, +7 more Locations Fudan University Shanghai Cancer Center — Shanghai, China View Trial Details
Recruiting Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel NCT05582538 Conditions Breast Diseases, Breast Neoplasms, Neoplasms, +5 more Locations Azienda Ospedaliero Universitaria Maggiore della Carità — Novara, Italy ASST Papa Giovanni XXIII — Bergamo, Italy Istituto Nazionale dei Tumori IRCCS — Milan, Italy IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale" — Naples, Italy View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Versus Platinum Chemotherapy in the Treatment of Second-/Third-line Triple Negative Breast Cancer (TNBC) NCT07413601 Conditions Breast Diseases, Breast Neoplasms, Neoplasms, +5 more Locations No. 17 Panjiayuan Nan Li, Chaoyang District, Beijing — Beijing, Beijing Municipality, China View Trial Details
